Dpy30-KO mice developed impaired glucose tolerance and had reduced serum insulin levels by 45 days post tamoxifen administration (Fig. 1i,j) and then rapidly developed diabetes (Fig. 1k,l), prompting euthanasia by 60 days. Here, DPY30 is linked to diabetes mellitus.